Category: United States
-
Moderna calls itself the âtrue innovatorâ in response to CureVac mRNA patent lawsuit, cites broken non-assert promise
Moderna has filed a response to CureVacâs mRNA patent suit, denying infringement, attacking the validity of all 10 patents, and calling the lawsuit âultimately a meritless attempt to claim success for work it never didâ.
-
Maxell notches partial USITC win against Samsung as Galaxy import ban recommended
It’s just one part of a multi-theater battle between the two Asian companies which has seen Maxell awarded, and subsequently stripped of, $112 million in damages.
-
Wendy’s, Gap, and other merchants hit in Texas PAE campaign asserting ex-Cypress Semiconductor patents
Near Field Electronics is targeting digital payments at a time when point-of-sale devices are becoming a patent hotspot.
-
Viasat prevails in $229M jury verdict against Japanese rival over NAND patent infringement
The U.S. District Court for the Western District of Texas has ruled that Kioxia owes Viasat $229 million for infringing one of its flash-memory patents.
-
Covid-19 vaccine makers Moderna and Pfizer hit with Sanofi suits over mRNA delivery tech
Sanofi and Translate Bio effectively abandoned their own Covid-19 vaccine effort in 2021 after the former acquired the latter.
-
Oura scores brace in U.S. as Zepp withdraws district court complaint, final Samsung IPR fails
It augurs well for the smart ring maker as positive developments at the PTAB, ITC, and in federal court add up.
-
Toyota found to be licensed to AutoConnect patents by previous Spangenberg deal; grant of summary judgment recommended
Eastern District of Texas Magistrate Judge Roy S. Payne found that AutoConnect Holdings’ short-lived transfer of patents to an IPwe-linked company encumbered them.
-
AT&T and Verizon accused of infringing former ZTE patents in Eastern District of Texas
Plaintiff Eight Deer Ventures LLC acquired the patents-in-suit from the Chinese tech giant in 2022 and 2023.
-
Federal Circuit upholds decision to throw out $107.5M patent infringement verdict against AstraZeneca
The precedential decision, confirming the invalidation of two of Pfizer subsidiary Wyethâs cancer drug-related patents, held that the plaintiff not only failed to rebut evidence on certain issues, but its own experts agreed against it.
-
Gallium nitride patent suit docket stacks up in the U.S.
Semiconductor tech maker Wolfspeed has filed a gallium nitride-related patent complaint against rival Navitas Semiconductor over the alleged infringement of five of its patents.